These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 37379962)

  • 1. Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.
    Chen T; Cheng L; Ma J; Yuan J; Pi C; Xiong L; Chen J; Liu H; Tang J; Zhong Y; Zhang X; Liu Z; Zuo Y; Shen H; Wei Y; Zhao L
    Pharmacol Res; 2023 Aug; 194():106837. PubMed ID: 37379962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contribution of serotonin 5-HT
    Ibi D
    Nihon Yakurigaku Zasshi; 2023 May; 158(3):229-232. PubMed ID: 36990794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine and other potential glutamate antidepressants.
    Dutta A; McKie S; Deakin JFW
    Psychiatry Res; 2015 Jan; 225(1-2):1-13. PubMed ID: 25467702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways.
    Ren L
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110910. PubMed ID: 38061484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
    Suzuki K; Monteggia LM
    Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect.
    Bottemanne H; Berkovitch L; Gauld C; Balcerac A; Schmidt L; Mouchabac S; Fossati P
    Neurosci Biobehav Rev; 2023 Nov; 154():105410. PubMed ID: 37793581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.
    Abdallah CG; Adams TG; Kelmendi B; Esterlis I; Sanacora G; Krystal JH
    Depress Anxiety; 2016 Aug; 33(8):689-97. PubMed ID: 27062302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine and the next generation of antidepressants with a rapid onset of action.
    Machado-Vieira R; Salvadore G; Diazgranados N; Zarate CA
    Pharmacol Ther; 2009 Aug; 123(2):143-50. PubMed ID: 19397926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
    Hashimoto K
    Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research.
    Lv S; Yao K; Zhang Y; Zhu S
    Neuropharmacology; 2023 Mar; 225():109378. PubMed ID: 36539011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.
    Pilc A; Machaczka A; Kawalec P; Smith JL; Witkin JM
    Expert Opin Drug Discov; 2022 Oct; 17(10):1131-1146. PubMed ID: 35934973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on NMDA antagonists in depression.
    Pochwat B; Nowak G; Szewczyk B
    Expert Rev Neurother; 2019 Nov; 19(11):1055-1067. PubMed ID: 31328587
    [No Abstract]   [Full Text] [Related]  

  • 14. Next generation antidepressants with novel mechanisms for treatment resistant depression.
    Chen MH; Tu PC; Su TP
    Prog Brain Res; 2023; 278():149-168. PubMed ID: 37414491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics.
    Kojic M; Saelens J; Kadriu B; Zarate CA; Kraus C
    Curr Top Behav Neurosci; 2022; 56():141-167. PubMed ID: 35312993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid-acting antidepressants.
    Witkin JM; Martin AE; Golani LK; Xu NZ; Smith JL
    Adv Pharmacol; 2019; 86():47-96. PubMed ID: 31378256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentially regulated targets in the fast-acting antidepressant effect of (R)-ketamine: A systems biology approach.
    Scotton E; Casa PL; de Abreu FP; de Avila E Silva S; Wilges RLB; Rossetto MV; Géa LP; Rosa AR; Colombo R
    Pharmacol Biochem Behav; 2023 Feb; 223():173523. PubMed ID: 36731751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine.
    Wohleb ES; Gerhard D; Thomas A; Duman RS
    Curr Neuropharmacol; 2017; 15(1):11-20. PubMed ID: 26955968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine for Major Depressive Disorder.
    Costi S
    Curr Top Behav Neurosci; 2024; 66():131-147. PubMed ID: 37922100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
    Autry AE; Adachi M; Nosyreva E; Na ES; Los MF; Cheng PF; Kavalali ET; Monteggia LM
    Nature; 2011 Jun; 475(7354):91-5. PubMed ID: 21677641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.